Nucleosomal structures of c-myc promoters with transcriptionally engaged RNA polymerase II

Molecular and Cellular Biology

Volumn 17, Issue 8, 1997, Pages 4363-4371

  Albert, Thomas ^a   Mautner, Josef ^a,b   Funk, Jens O ^a,c   Hörtnagel, Konstanze ^a,d   Pullner, Andrea ^a   Eick, Dirk ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MYC PROTEIN; RNA POLYMERASE II;

ARTICLE; CHROMATIN STRUCTURE; CONTROLLED STUDY; GENE DISRUPTION; GENE INDUCTION; GENE STRUCTURE; GENETIC ORGANIZATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NUCLEOSOME; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; RAJI CELL; SIGNAL TRANSDUCTION;

EID: 0030853935     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.8.4363     Document Type: Article

References (80)

1. Adams, C. C., and J. L. Workman. 1993. Nucleosomal displacement in transcription. Cell 72:305-308.
2. Archer, T. K., M. G. Cordingley, R. G. Wolford, and G. L. Hager. 1991. Transcription factor access is mediated by accurately positioned nucleosomes on the mouse mammary tumor virus promoter. Mol. Cell. Biol. 11: 688-698.
3. Archer, T. K., P. Lefebvre, R. G. Wolford, and G. L. Hager. 1992. Transcription factor loading on the MMTV promoter: a bimodal mechanism for promoter activation. Science 255:1573-1576.
4. Asselin, C., A. Nepveu, and K. B. Marcu. 1989. Molecular requirements for transcriptional initiation of the murine c-myc gene. Oncogene 4:549-558.
5. Axelrod, J. P., M. S. Reagan, and J. Majors. 1993. Gal4 disrupts a repressing nucleosome during activation of GAL1 transcription in vivo. Genes Dev. 7:857-869.
6. Becker, P. B. 1994. The establishment of active promoters in chromatin. Bioessays 16:541-547.
7. Bentley, D. L., and M. Groudine. 1986. A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells. Nature 321:702-706.
8. Berk, A. J., and P. A. Sharp. 1977. Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids. Cell 12:721-732.
9. Cesarman, E., F. R. Dalla, D. Bentley, and M. Groudine. 1987. Mutations in the first exon are associated with altered transcription of C-myc in Burkitt lymphoma. Science 238:1272-1275.
10. Collins, S., and M. Groudine. 1982. Amplification of endogenous myc-related DNA sequences in a human myeloid leukaemia cell line. Nature 298: 679-681.
11. Dalla Favera, R., F. Wong-Staal, and R. C. Gallo. 1982. onc gene amplification in promyelocytic leukaemia cell line HL-60 and primary leukaemic cells of the same patient. Nature 299:61-63.
12. Dyson, P. J., T. D. Littlewood, A. Forster, and T. H. Rabbitts. 1985. Chromatin structure of transcriptionally active and inactive human c-myc alleles. EMBO J. 4:2885-2891.
13. Eick, D., and G. W. Bornkamm. 1986. Transcriptional arrest within the first exon is a fast control mechanism in c-myc expression. Nucleic Acids Res. 14:8331-8346.
14. Eick, D., A. Polack, E. Kofler, and G. W. Bornkamm. 1988. The block of elongation in C-myc exon 1 is abolished in Burkitt's lymphoma cell lines with variant translocation. Oncogenc 3:397-403.
15. Fahrlander, P. D., M. Piechaczyk, and K. B. Marcu. 1985. Chromatin structure of the murine c-myc locus: implications for the regulation of normal and chromosomally translocated genes. EMBO J. 4:3195-3202.
16. Felsenfeld, G. 1992. Chromatin as an essential part of the transcriptional mechanism. Nature 355:219-224.
17. Garrity, P. A., and B. J. Wold. 1992. Effects of different DNA polymerases in ligation-mediated PCR: enhanced genomic sequencing and in vivo footprinting. Proc. Natl. Acad. Sci. USA 89:1021-1025.
18. Gazin, C., S. Dupont de Dinechin, A. Hampe, J. M. Masson, P. Martin, D. Stehelin, and F. Galibert. 1984. Nucleotide sequence of the human c-myc locus: provocative open reading frame within the first exon. EMBO J. 3:383-387.
19. Grunstein, M. 1990. Histone function in transcription. Annu. Rev. Cell Biol. 6:643-678.
20. Hall, D. J. 1990. Regulation of C-myc transcription in vitro: dependence on the guanine-rich promoter element ME1a1. Oncogene 5:47-54.
21. Han, M., and M. Grunstein. 1988. Nucleosome loss activates yeast downstream promoters in vivo. Cell 55:1137-1145.
22. Hörtnagel, K., J. Mautner, L. J. Strobl, D. A. Wolf, B. Christoph, C Geltinger, and A. Polack. 1995. The role of immunoglobulin kappa elements in c-myc activation. Oncogene 10:1393-1401.
23. Jücker, M., A. J. Roebroek, J. Mautner, K. Koch, D. Eick, V. Diehl, W. J. M. van de Yen, and H. Tesch. 1992. Expression of truncated transcripts of the proto-oncogene c-fps/fes in human lymphoma and lymphoid leukemia cell lines. Oncogene 7:943-952.
24. Kavathas, P., F. H. Bach, and R. DeMars. 1980. Gamma ray-induced loss of expression of HLA and glyoxalase I alieles in lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 77:4251-4255.
25. Kohlhuber, F., L. J. Strobl, and D. Eick. 1993. Early down-regulation of c-myr in dimethylsulfoxide-induced mouse erythroleukemia (MEL) cells is mediated at the P1/P2 promoters. Oncogene 8:1099-1102.
26. Kornberg, R. D., and Y. Lorch. 1992. Chromatin structure and transcription. Annu. Rev. Cell Biol. 8:563-587.
27. Krumm, A., T. Meulia, M. Brunvand, and M. Groudine. 1992. The block to transcriptional elongation within the human c-myc gene is determined in the promoter-proximal region. Genes Dev. 6:2201-2213.
28. Krumm, A., L. B. Hickey, and M. Groudine. 1995. Promoter-proximal pausing of RNA polymerase 11 defines a general rate-limiting step after transcription initiation. Genes Dev. 9:559-572.
29. Lavenu, A., S. Pournin, C. Babinet, and D. Morello. 1994. The cis-acting elements known to regulate c-myc expression ex vivo are not sufficient for correct transcription in vivo, Oncogene 9:527-536.
30. Lee, H. L., and T. K. Archer. 1994. Nucleosome-mediated disruption of transcription factor-chromatin initiation complexes at the mouse mammary tumor virus long terminal repeat in vivo. Mol. Cell. Biol. 14:32-41.
31. Lis, J. T., and C. Wu. 1993. Protein traffic on the heat shock promoter: parking, stalling, and trucking along. Cell 74:1-4.
32. Lyons, R. M., and H. L. Moses. 1990. Transforming growth factors and the regulation of cell proliferation. Eur. J. Biochem. 187:467-473.
33. Madisen, L., and M. Groudine. 1994. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells. Genes Dev. 8:2212-2226.
34. Marcu, K. B., S. A. Bossone, and A. J. Patel. 1992. myc function and regulation. Annu. Rev. Biochem. 61:809-860.
35. Mautner, J., S. Joos, T. Werner, D. Eick, G. W. Bornkamm, and A. Polack. 1995. Identification of two enhancer elements downstream of the human c-myc gene. Nucleic Acids Res. 23:72-80.
36. McCracken, S., N. Fong, K. Yankulov, S. Ballantyne, G. Pan, J. Greenblatt, S. D. Patterson, M. Wickens, and D. L. Bentley. 1997. The C-terminal domain of RNA polymerase II couples mRNA processing to transcription. Nature 385:357-361.
37. II250 subunit of TFIID has histone acetyltransferase activity. Cell 87:1261-1270.
38. Miller, H., C. Asselin, D. Dufort, J. Q. Yang, K. Gupta, K. B. Marcu, and A. Nepveu. 1989. A cis-acting element in the promoter region of the murine c-myc gene is necessary for transcriptional block. Mol. Cell. Biol. 9:5340-5349.
39. Mueller, P. R., and B. Wold. 1989. In vivo footprinting of a muscle specific enhancer by ligation mediated PCR. Science 246:780-786.
40. Mymryk, J. S., and T. K. Archer. 1995. Dissection of progesterone receptor-mediated chromatin remodeling and transcriptional activation in vivo. Genes Dev. 9:1366-1376.
41. Mymryk, J. S., D. Berard, G. L. Hager, and T. K. Archer. 1995. Mouse mammary tumor virus chromatin in human breast cancer cells is constitutively hypersensitive and exhibits steroid hormone-independent loading of transcription factor in vivo. Mol. Cell. Biol. 15:26-34.
42. Nepveu, A., and K. B. Marcu. 1986. Intragenic pausing and anti-sense transcription within the murine c-myc locus. EMBO J. 5:2859-2865.
43. Nishikura, K. 1986. Sequences involved in accurate and efficient transcription of human c-myc genes microinjected into frog oocytes. Mol. Cell. Biol. 6:4093-4098.
44. O'Brien, T., and J. T. Lis. 1993. Rapid changes in Drosophila transcription after an instantaneous heat shock. Mol. Cell. Biol. 13:3456-3463.
45. Ogryzko, V. V., R. L. Schiltz, V. Russanova, B. H. Howard, and Y. Nakatani. 1996. The transcriptional coaclivators p300 and CBP are histone acetyltransferases. Cell 87:953-959.
46. Paranjape, S. M., R. T. Kamakaka, and J. T. Kadonaga. 1994. Role of chromatin structure in the regulation of transcription by RNA polymerase II. Annu. Rev. Biochem. 63:265-297.
47. Pazin, M. J., P. L. Sheridan, K. Cannon, Z. Cao, J. G. Keck, J. T. Kadonaga, and K. A. Jones. 1996. NF-κB-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro. Genes Dev. 10:37-49.
48. Pina, B., U. Brüggemeier, and M. Beato. 1990. Nucleosome positioning modulates accessibility of regulatory proteins to the mouse mammary tumor virus promoter. Cell 60:719-731.
49. Plet, A., D. Eick, and J. M. Blanchard. 1995. Elongation and premature termination of transcripts initiated from c-fos and c-myc promoters show dissimilar patterns. Oncogene 10:318-328.
50. Polack, A., D. Eick, E. Koch, and G. W. Bornkamm. 1987. Truncation does not abrogate transcriptional downregulation of the c-myc gene by sodium butyrate in Burkitt's lymphoma cells. EMBO J. 6:2959-2964.
51. Polack, A., L. Strobl, R. Feederle, M. Schweizer, E. Koch, D. Eick, H. Wiegand, and G. W. Bornkamm. 1991. The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkittspecific promoter shift. Oncogene 6:2033-2040.
52. Polack, A., R. Feederle, G. Klobeck, and K. Hörtnagel. 1993. Regulatory elements in the immunoglobulin kappa locus induce c-myc activation and the promoter shift in Burkitt's lymphoma cells. EMBO J. 12:3913-3920.
53. Pullner, A., J. Mautner, T. Albert, and D. Eick. 1996. Nucleosomal structure of active and inactive c-myc genes. J. Biol. Chem. 271:31452-31457.
54. Pulvertaft, R. J. V. 1964. Cytology of Burkitt's tumor (African lymphoma). Lancet i:238-240.
55. Rasmussen, E. B., and J. T. Lis. 1995. Short transcripts of the ternary complex provide insight into RNA polymerase II elongational pausing. J. Mol. Biol. 252:522-535.
56. Richard-Foy, H., and G. Hager. 1987. Sequence-specific positioning of nucleosomes over the steroid-inducible MMTV promoter. EMBO J. 6:2321-2328.
57. Riggs, M. G., R. G. Whittaker, J. R. Neumann, and V. M. Ingram. 1977. n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells. Nature 268:462-464.
58. Rougvie, A. E., and J. T. Lis. 1988. The RNA polymerase II molecule at the 5′ end of the uninduced hsp70 gene of D. melanogaster is transcriptionally engaged. Cell 54:795-804.
59. Rougvie, A. E., and J. T. Lis. 1990. Postinitiation transcriptional control in Drosophila melanogaster. Mol. Cell. Biol. 10:6041-6045.
60. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
61. Schmid, A., K. D. Fascher, and W. Hörz. 1992. Nucleosome disruption at the yeast PHO5 promoter upon PHO5 induction occurs in the absence of DNA replication. Cell 71:853-864.
62. Shopland, L., K. Hirayoshi, M. Fernandes, and J. T. Lis. 1995. HSF access to heat shock elements in vivo depends critically on promoter architecture defined by GAGA factor, TFIID, and RNA polymerase II binding sites. Genes Dev. 9:2756-2769.
63. Siebenlist, U., L. Hennighausen, J. Battey, and P. Leder. 1984. Chromatin structure and protein binding in the putative regulatory region of the c-myc gene in Burkitt lymphoma. Cell 37:381-391.
64. Siebenlist, U., P. Bressler, and K. Kelly. 1988. Two distinct mechanisms of transcriptional control operate on c-myc during differentiation of HL60 cells. Mol. Cell. Biol. 8:867-874.
65. Spencer, C. A., and M. Groudine. 1990. Transcription elongation and eukaryotic gene regulation. Oncogene 5:777-785.
66. Strobl, L. J., and D. Eick. 1992. Hold back of RNA polymerase II at the transcription start site mediates down-regulation of c-mvc in vivo. EMBO J. 11:3307-3314.
67. Strobl, L. J., F. Kohlhuber, J. Mautner, A. Polack, and D. Eick. 1993. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift. Oncogene 8:1437-1447.
68. Sugden, B., K. Marsh, and J. Yates. 1985. A vector that replicates as a plasmid and can be efficiently selected in B lymphoblasts transformed by Epstein-Barr virus. Mol. Cell. Biol. 5:410-413.
69. Svaren, J., and W. Hörz. 1996. Regulation of gene expression by nucleosomes. Curr. Opin. Genet. Dev. 6:164-170.
70. Taylor, I. C. A., J. L. Workman, T. J. Schuetz, and R. E. Kingston. 1991. Facilitated binding of GAL4 and heat shock factor to nucleosomal templates: differential function of DNA-binding domains. Genes Dev. 5:1285-1298.
71. Thalmeier, K., H. Synovzik, R. Mertz, E. L. Winnacker, and M. Lipp. 1989. Nuclear factor E2F mediates basic transcription and trans-activation by E1a of the human MYC promoter. Genes Dev. 3:527-536.
72. Truss, M., J. Bartsch, A. Schellbert, R. J. G. Haché, and M. Beato. 1995. Hormone induces binding of receptors and transcription factors to a rearranged nucleosome on the MMTV promoter in vivo. EMBO J. 14:1737-1751.
73. VanLint, C., S. Emiliani, M. Ott, and E. Verdin. 1996. Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J. 15:1112-1120.
74. Venter, U., J. Svaren, J. Schmitz, A. Schmid, and W. Hörz. 1994. A nucleosome precludes binding of the transcription factor Pho4 in vivo to a critical target site in the PHO5 promoter. EMBO J. 13:4848-4855.
75. Verdin, E., P. J. Paras, and C. Van Lint. 1993. Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO J. 12:3249-3259.
76. Verdone, L., G. Camilloni, E. Di Mauro, and M. Caserta. 1996. Chromatin remodeling during Saccharomyces cerevisiae ADH2 gene activation. Mol. Cell. Biol. 16:1978-1988.
77. Wang, W., M. Carey, and J. D. Gralla. 1992. Polymerase II promoter activation: closed complex formation and ATP-driven start site opening. Science 255:450-453.
78. Wolf, D. A., L. J. Strobl, A. Pullner, and D. Eick. 1995. Variable pause positions of RNA polymerase II lie proximal to the c-myc promoter irrespective of transcriptional activity. Nucleic Acids Res. 23:3373-3379.
79. Wolffe, A. P. 1994. Transcription: in tune with the histones. Cell 77:13-16.
80. Yankulov, K., J. Blau, T. Purton, S. Roberts, and D. L. Bentley. 1994. Transcriptional elongation by RNA polymerase II is stimulated by transactivators. Cell 77:749-759.